268 related articles for article (PubMed ID: 9708500)
1. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
Mäki MT; Haaparanta M; Nuutila P; Oikonen V; Luotolahti M; Eskola O; Knuuti JM
J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500
[TBL] [Abstract][Full Text] [Related]
2. 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
Takala TO; Nuutila P; Pulkki K; Oikonen V; Grönroos T; Savunen T; Vähäsilta T; Luotolahti M; Kallajoki M; Bergman J; Forsback S; Knuuti J
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1617-22. PubMed ID: 12458396
[TBL] [Abstract][Full Text] [Related]
3. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
Turpeinen AK; Takala TO; Nuutila P; Axelin T; Luotolahti M; Haaparanta M; Bergman J; Hämäläinen H; Iida H; Mäki M; Uusitupa MI; Knuuti J
Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium.
Mäki MT; Haaparanta MT; Luotolahti MS; Nuutila P; Voipio-Pulkki LM; Bergman JR; Solin OH; Knuuti JM
Am J Physiol; 1997 Nov; 273(5):H2473-80. PubMed ID: 9374787
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection.
Ebert A; Herzog H; Stöcklin GL; Henrich MM; DeGrado TR; Coenen HH; Feinendegen LE
J Nucl Med; 1994 Jan; 35(1):51-6. PubMed ID: 8271060
[TBL] [Abstract][Full Text] [Related]
7. Myocardial uptake of the fatty acid analog 14-fluorine-18-fluoro-6-thia-heptadecanoic acid in comparison to beta-oxidation rates by tritiated palmitate.
Stone CK; Pooley RA; DeGrado TR; Renstrom B; Nickles RJ; Nellis SH; Liedtke AJ; Holden JE
J Nucl Med; 1998 Oct; 39(10):1690-6. PubMed ID: 9776270
[TBL] [Abstract][Full Text] [Related]
8. Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET.
Asola MR; Virtanen KA; Peltoniemi P; Någren K; Yu M; Mattila K; Jyrkkiö S; Metsärinne K; Nuutila P; Knuuti J
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1485-91. PubMed ID: 12397468
[TBL] [Abstract][Full Text] [Related]
9. 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids.
DeGrado TR; Coenen HH; Stocklin G
J Nucl Med; 1991 Oct; 32(10):1888-96. PubMed ID: 1919727
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia.
Guiducci L; Grönroos T; Järvisalo MJ; Kiss J; Viljanen A; Naum AG; Viljanen T; Savunen T; Knuuti J; Ferrannini E; Salvadori PA; Nuutila P; Iozzo P
J Nucl Med; 2007 Mar; 48(3):455-62. PubMed ID: 17332624
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fatty acid tracers FTHA and BMIPP during myocardial ischemia and hypoxia.
Renstrom B; Rommelfanger S; Stone CK; DeGrado TR; Carlson KJ; Scarbrough E; Nickles RJ; Liedtke AJ; Holden JE
J Nucl Med; 1998 Oct; 39(10):1684-9. PubMed ID: 9776269
[TBL] [Abstract][Full Text] [Related]
12. Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET.
Iozzo P; Turpeinen AK; Takala T; Oikonen V; Solin O; Ferrannini E; Nuutila P; Knuuti J
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1160-4. PubMed ID: 12811532
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
14. Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET.
Schulz G; von Dahl J; Kaiser HJ; Koch KC; Sabri O; Banneitz L; Cremerius U; Buell U
Nucl Med Commun; 1996 Dec; 17(12):1057-64. PubMed ID: 9004303
[TBL] [Abstract][Full Text] [Related]
15. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.
Kurata C; Wakabayashi Y; Shouda S; Mikami T; Takei Y; Tawarahara K; Sugiyama T; Nakano T; Fujisawa S; Andoh A
J Nucl Med; 1997 Jul; 38(7):1079-84. PubMed ID: 9225794
[TBL] [Abstract][Full Text] [Related]
16. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Paternostro G; Camici PG; Lammerstma AA; Marinho N; Baliga RR; Kooner JS; Radda GK; Ferrannini E
J Clin Invest; 1996 Nov; 98(9):2094-9. PubMed ID: 8903329
[TBL] [Abstract][Full Text] [Related]
17. The effect of insulin and FFA on myocardial glucose uptake.
Knuuti MJ; Mäki M; Yki-Järvinen H; Voipio-Pulkki LM; Härkönen R; Haaparanta M; Nuutila P
J Mol Cell Cardiol; 1995 Jul; 27(7):1359-67. PubMed ID: 7473782
[TBL] [Abstract][Full Text] [Related]
18. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
Ng CK; Soufer R; McNulty PH
J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
[TBL] [Abstract][Full Text] [Related]
19. The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats.
Ci X; Frisch F; Lavoie F; Germain P; Lecomte R; van Lier JE; Bénard F; Carpentier AC
Mol Imaging Biol; 2006; 8(4):237-44. PubMed ID: 16791750
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
